IMD Annual International Alumni Event 2019 Executive Summary Our planet has reached a critical moment. Glaciers are melting, sea levels are rising, many species are
Zambon, a privately held long-established Italian multinational company, extends its presence in severe respiratory diseases through the acquisition of Breath Therapeutics, a biopharmaceutical company developing
Univercells and consortium partner Batavia Biosciences have been awarded a $4 million grant extension by the Bill & Melinda Gates Foundation to scale up their
“Opinion de Pierre Morgon, fondateur et CEO de MRGN Advisors et partner pour la Suisse chez Mérieux Développement.”BIOTECHFINANCES • Lundi 29 janvier 2018
Dr. Morgon, a 30-year pharma industry veteran, will bring vast experience and business expertise to Alma as it progresses towards the clinical trial of a therapeutic drug
AJ Pharma makes its first acquisition in Denmark, creating an independent entity from the state-owned SSI vaccine production business through its subsidiary, AJ Biologics.This will
Schlieren, Switzerland (25.01.2017) – Virometix today announced the appointment of Dr. Pierre A.Morgon, PharmD, LL.M., MBA as Chairman and Dr. Isaac Kobrin as independent member
This chapter focuses on the evolution of the priorities and processes of the life science industry driven by an increasing orientation on the patient. The
MRGN Advisors
Rue du Mont-Blanc 4
Case postale 2067
CH – 1211 Genèva 1
Switzerland
